References
- Nadeau KJ, Anderson BJ, Berg EG, Chiang JL, Chou H, Copeland KC, et al. Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities. Diabetes Care. 2016;39:1635-1642. https://doi.org/10.2337/dc16-1066
- Shaw JE, Zimmet PZ, McCarty D, de Courten M. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care. 2000;23:B5-10
- Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001;413:131-138. https://doi.org/10.1038/35093050
- Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009;41:527-534. https://doi.org/10.1038/ng.357
- Qiu L, Fan X, Zhang Y, Teng X, Miao Y. Molecular characterization, tissue expression and polymorphisms of buffalo PPARGC1A gene. Arch Anim Breed. 2020;63:249-259. https://doi.org/10.5194/aab-63-249-2020
- Esterbauer H, Oberkofler H, Krempler F, Patsch W. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics. 1999;62:98-102. https://doi.org/10.1006/geno.1999.5977
- Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829-839. https://doi.org/10.1016/s0092-8674(00)81410-5
- Clark J, Reddy S, Zheng K, Betensky RA, Simon DK. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. BMC Med Genet. 2011;12:69. https://doi.org/10.1186/1471-2350-12-69
- Che HV, Metzger S, Portal E, Deyle C, Riess O, Nguyen HP. Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease. Mol Neurodegener. 2011;6:1. https://doi.org/10.1186/1750-1326-6-1
- Salazar G, Cullen A, Huang J, Zhao Y, Serino A, Hilenski L, et al. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence. Autophagy. 2020;16:1092-1110. https://doi.org/10.1080/15548627.2019.1659612
- Soyal S, Krempler F, Oberkofler H, Patsch W. PGC-1 alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia. 2006;49:1477-1488. https://doi.org/10.1007/s00125-006-0268-6
- Zhu Li, Huang Q, Xie Z, Kang M, Ding H, Chen B, et al. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level. Oncotarget. 2017;8:37308-37320. https://doi.org/10.18632/oncotarget.16307
- Park S, Kim BC, Kang S. Interaction effect of PGC-1α rs10517030 variants and energy intake in the risk of type 2 diabetes in middle-aged adults. Eur J Clin Nutr. 2017;71:1442-1448. https://doi.org/10.1038/ejcn
- Totomoch-Serra A, Munoz ML, Burgueno J, Revilla-Monsalve MC, Diaz-Badillo A. Association of common polymorphisms in the VEGFA and SIRT1 genes with type 2 diabetes-related traits in Mexicans. Arch Med Sci. 2018;14:1361-1373. https://doi.org/10.5114/aoms.2018.74757
- Cheema AK, Li T, Liuzzi JP, Zarini GG, Dorak MT, Huffman FG. Genetic associations of PPARGC1A with type 2 diabetes: differences among populations with African origins. J Diabetes Res. 2015;2015:921274. https://doi.org/10.1155/2015/921274
- Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). J Biol Chem. 1995;270:12953-12956. https://doi.org/10.1074/jbc.270.22.12953
- Kim JH, Shin HD, Park BL, Cho YM, Kim SY, Lee HK, et al. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population. Diabetologia. 2005;48:1323-1330. https://doi.org/10.1007/s00125-005-1793-4